Hims & Hers Health, Inc. (NYSE:HIMS) Receives $37.31 Average Price Target from Analysts

Hims & Hers Health, Inc. (NYSE:HIMS) has received a consensus recommendation of “Hold” from the fifteen analysts that are presently covering the stock, Marketbeat reports. Two analysts have rated the stock with a sell recommendation, seven have assigned a hold recommendation and six have assigned a buy recommendation to the company. The average 12-month price target among brokers that have issued ratings on the stock in the last year is $37.31.

Several analysts have issued reports on HIMS shares. Truist Financial raised their price objective on shares of Hims & Hers Health from $24.00 to $39.00 and gave the stock a “hold” rating in a research note on Wednesday, February 26th. Leerink Partners raised their price target on Hims & Hers Health from $24.00 to $40.00 and gave the stock a “market perform” rating in a research note on Tuesday, February 25th. Needham & Company LLC upped their price objective on Hims & Hers Health from $31.00 to $61.00 and gave the company a “buy” rating in a research report on Tuesday, February 25th. Piper Sandler lifted their target price on Hims & Hers Health from $24.00 to $35.00 and gave the stock a “neutral” rating in a research report on Tuesday, February 25th. Finally, Canaccord Genuity Group upped their price target on shares of Hims & Hers Health from $38.00 to $68.00 and gave the stock a “buy” rating in a report on Wednesday, February 19th.

Hims & Hers Health Stock Down 8.8 %

Shares of HIMS opened at $29.11 on Wednesday. The business has a fifty day moving average of $39.88 and a 200 day moving average of $29.58. The company has a market cap of $6.47 billion, a PE ratio of 66.15 and a beta of 1.37. Hims & Hers Health has a 52-week low of $11.20 and a 52-week high of $72.98.

Hims & Hers Health (NYSE:HIMS) last announced its earnings results on Monday, February 24th. The company reported $0.11 earnings per share for the quarter, beating the consensus estimate of $0.09 by $0.02. Hims & Hers Health had a net margin of 8.19% and a return on equity of 10.97%. The business had revenue of $481.14 million for the quarter, compared to the consensus estimate of $494.56 million. As a group, research analysts anticipate that Hims & Hers Health will post 0.29 earnings per share for the current fiscal year.

Insider Activity

In related news, CFO Oluyemi Okupe sold 11,581 shares of the firm’s stock in a transaction dated Monday, January 13th. The stock was sold at an average price of $24.44, for a total transaction of $283,039.64. Following the sale, the chief financial officer now owns 118,077 shares of the company’s stock, valued at $2,885,801.88. This trade represents a 8.93 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Soleil Boughton sold 268,932 shares of Hims & Hers Health stock in a transaction dated Monday, January 6th. The shares were sold at an average price of $27.75, for a total value of $7,462,863.00. Following the completion of the transaction, the insider now owns 169,803 shares in the company, valued at $4,712,033.25. This trade represents a 61.30 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 1,061,718 shares of company stock worth $37,894,395. 17.71% of the stock is currently owned by corporate insiders.

Institutional Trading of Hims & Hers Health

Several hedge funds have recently modified their holdings of the company. California State Teachers Retirement System grew its position in shares of Hims & Hers Health by 18.8% in the 4th quarter. California State Teachers Retirement System now owns 166,337 shares of the company’s stock worth $4,022,000 after buying an additional 26,363 shares during the last quarter. Wealth Enhancement Advisory Services LLC acquired a new stake in Hims & Hers Health in the fourth quarter valued at approximately $213,000. IronOak Wealth LLC. purchased a new position in Hims & Hers Health in the fourth quarter worth $922,000. Kilter Group LLC acquired a new position in shares of Hims & Hers Health during the fourth quarter worth $1,053,000. Finally, Cim LLC lifted its holdings in shares of Hims & Hers Health by 1.0% during the 4th quarter. Cim LLC now owns 71,869 shares of the company’s stock valued at $1,738,000 after purchasing an additional 694 shares during the last quarter. 63.52% of the stock is owned by hedge funds and other institutional investors.

About Hims & Hers Health

Hims & Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.